---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-030145"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2024-08-05T23:59:59+00:00"
generated_at: "2026-05-31T13:13:59.397599+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# TenX Keane shareholders approve business combination with Citius Oncology; redemptions total $49.3M

## Summary
- All eight proposals approved, including business combination, domestication to Delaware, name change to Citius Oncology, and 15M-share stock incentive plan.
- 4,297,828 shares redeemed at ~$11.46 per share, aggregating $49,265,965 from trust account.
- Eight directors elected to staggered terms: Myron Holubiak, Joel Mayersohn, Dr. Eugene Holuka, Robert Smith, Carol Webb, Suren Dutia, Leonard Mazur, Dennis McGrath.
- Business combination involves Citius Oncology (spin-off from Citius Pharma) merging into TenX; closing conditions still pending.
- Incentive plan authorizes options, SARs, restricted stock, RSUs, and cash awards for employees, directors, and consultants.

## SEC filing metadata
- accession: 0001493152-24-030145
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2024-08-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000149315224030145/0001493152-24-030145-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000149315224030145/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-030145
- JSON: https://secwatch.observer/filing/0001493152-24-030145.json
- Plain text: https://secwatch.observer/filing/0001493152-24-030145.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.